BLRX

BioLineRx Ltd. - American Depositary Shares (BLRX)

About BioLineRx Ltd. - American Depositary Shares (BLRX)

BioLineRx Ltd. is a clinical stage biopharmaceutical company, which engages in the research and development of treatments that focus on cancer. Its product pipeline includes Motaxafortide (BL-8040), which is used for stem-cell mobilization, solid tumors, and acute myeloid lukemia; and AGI-134, which is an immunotherapy treatment used for multiple solid tumors. The company was founded in 2003 and is headquartered in Modi'in, Israel.

Details

Daily high

$3.10

Daily low

$2.92

Price at open

$2.96

52 Week High

$14.70

52 Week Low

$2.30

Market cap

13.2M

Dividend yield

0.00%

Volume

20,218

Avg. volume

27,763

P/E ratio

-2.23

BioLineRx Ltd. - American Depositary Shares News